"Insulin Detemir" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.
| Descriptor ID |
D000069057
|
| MeSH Number(s) |
D06.472.699.587.200.300.050 D12.644.548.586.200.300.050
|
| Concept/Terms |
Insulin Detemir- Insulin Detemir
- Detemir, Insulin
- Basal Insulin Detemir
- Detemir, Basal Insulin
- Insulin Detemir, Basal
B29-tetradecanoyl-Lys-B30-des-Ala-insulin- B29-tetradecanoyl-Lys-B30-des-Ala-insulin
- B29 tetradecanoyl Lys B30 des Ala insulin
- Insulin, Tetradecanoyl-Lys(B29)-des-Ala(B30)
- 12C-Lys(B29)-DB30I
- Des-(B30)-insulin, Lys(B29)-tetradecanoyl
- Insulin, Tetradecanoyllysyl(B29)-desalanyl(B30)
|
Below are MeSH descriptors whose meaning is more general than "Insulin Detemir".
Below are MeSH descriptors whose meaning is more specific than "Insulin Detemir".
This graph shows the total number of publications written about "Insulin Detemir" by people in this website by year, and whether "Insulin Detemir" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2017 | 3 | 0 | 3 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Insulin Detemir" by people in Profiles.
-
Newly-onset type 1 diabetes mellitus precipitated by COVID-19 in an 8-month-old infant. Acta Biomed. 2020 07 13; 91(3):ahead of print.
-
Effects of insulin analogs as an add-on to metformin on cutaneous microcirculation in type 2 diabetic patients. Microvasc Res. 2018 03; 116:6-14.
-
COMPARISON OF EFFICACY AND SAFETY OF GLARGINE AND DETEMIR INSULIN IN THE MANAGEMENT OF INPATIENT HYPERGLYCEMIA AND DIABETES. Endocr Pract. 2017 Sep; 23(9):1059-1066.
-
Comparative effectiveness and safety of different basal insulins in a real-world setting. Diabetes Obes Metab. 2017 08; 19(8):1116-1126.
-
A patient centred approach to basal insulin choice for the management of type 2 diabetes mellitus. J Pak Med Assoc. 2016 Mar; 66(3):360-1.